
Ifytrox SB 250mg/125mg Injection
Marketer
Sanify Healthcare Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Ifytrox SB 250mg/125mg Injection
Combiflox, a 250mg/125mg injectable antibiotic, combats various bacterial infections by inhibiting microbial growth and propagation. Administration must be under a doctor's guidance; adhere strictly to the prescribed dosage schedule. Complete the full course of treatment, regardless of symptom improvement; premature cessation may compromise efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening symptoms or allergic reactions (rash, itching, swelling, respiratory distress) immediately. Inform your physician of all concurrent medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While typically non-impairing, avoid driving if experiencing drowsiness or dizziness. Ensure adequate rest, nutrition, and hydration for optimal recovery. Monitoring through laboratory tests may be conducted to assess treatment response.
Uses of Ifytrox SB 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Ifytrox SB 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Ifytrox SB 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ifytrox SB 250mg/125mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Ifytrox SB 250mg/125mg Injection works:
The injectable formulation Ifytrox SB, containing 250mg Ceftriaxone and 125mg Sulbactam, employs a dual-action mechanism. Ceftriaxone, an antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial viability. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thus augmenting Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from ingesting alcohol while receiving Ifytrox SB 250mg/125mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Ifytrox SB, containing 250mg/125mg, is typically deemed safe for pregnant individuals. Preclinical trials using animals revealed minimal or no negative impacts on fetal development; however, research involving human subjects is currently insufficient.
Breast feedingCAUTION
The administration of Ifytrox SB 250mg/125mg Injection necessitates careful consideration during lactation. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
The Ifytrox SB 250mg/125mg Injection can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ifytrox SB 250mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
For patients with severe hepatic impairment, Ifytrox SB 250mg/125mg Injection requires careful administration and potential dosage modification. A physician's consultation is advised. Dosage alteration of Ifytrox SB 250mg/125mg Injection is unnecessary for individuals exhibiting mild to moderate liver dysfunction.
What if you forget to take Ifytrox SB 250mg/125mg Injection :
Should you inadvertently omit a scheduled dose of Ifytrox SB 250mg/125mg Injection, seek guidance from your physician.
Facts to Know About Ifytrox SB 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
